Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2013; 109(01): 195-196
DOI: 10.1160/TH13-02-0111
DOI: 10.1160/TH13-02-0111
Letters to the Editor
Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: A prospective cohort study
Financial support: This work was supported by NIH grant R01HL066176, a grant from the Doris Duke Charitable Foundation, and the USDA, Agricultural Research Service under Cooperative Agreement No. 58–1950–7–707. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the authors, and do not necessarily reflect the view of the USDA or the National Institutes of Health.
Further Information
Publication History
Received:
09 February 2013
Accepted after minor revision:
11 March 2013
Publication Date:
30 November 2017 (online)
-
References
- 1 Rombouts EK, Rosendaal FR, Van der Meer FJM. Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. Br J Haematol 2010; 149: 598-605.
- 2 Sconce E, Khan T, Mason J. et al. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005; 93: 872-875.
- 3 Pedersen F, Hamberg O, Hess K. et al. The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med 1991; 229: 517-520.
- 4 Ansell J, Hirsh J, Hylek E. et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (8th Edition). Chest 2008; 133 (06) Suppl: 160S-198S.
- 5 Platt AB, Localio AR, Brensinger CM. et al. Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Chest 2009; 137: 883-889.
- 6 Couris RR, Tataronis GR, Booth SL. et al. Development of a self-assessment instrument to determine daily intake and variability of dietary vitamin K. J Am Coll Nutr 2000; 19: 801-807.
- 7 Rosendaal F, Cannegieter S, Van der Meer F. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
- 8 Palareti G, Cosmi B. Bleeding with anticoagulation therapy who is at risk, and how best to identify such patients. Thromb Haemost 2009; 102: 268-278.
- 9 Booth SL, Centurelli M. Vitamin K: a practical guide to the dietary management of patients on warfarin. Nutrition Rev 1999; 57: 288-296.
- 10 Johnson M. Influence of Vitamin K on Anticoagulant Therapy Depends on Vitamin K Status and the Source and Chemical Forms of Vitamin K. Nutrition Rev 2005; 63: 91-100.
- 11 Warren Grant Magnuson Clinical Center. National Institutes of Health Drug Interaction Task Force. Important information to know when you are taking: Coumadin® and vitamin K. 2003 Available at: http://ods.od.nih.gov/pubs/factsheets/coumad-in1.pdf
- 12 Thane CW, Paul aa, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ. Intake and sources of phylloquinone (vitamin K1): variation with sociodemographic and lifestyle factors in a national sample of British elderly people. Br J Nutr 2007; 87: 605.
- 13 Sconce E, Avery P, Wynne H. et al. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007; 109: 2419-2423.